Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
基本信息
- 批准号:9096719
- 负责人:
- 金额:$ 74.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adenosine Diphosphate RiboseAffectAmino Acid SequenceAnimalsAntiviral AgentsAntiviral TherapyAttenuatedBiochemicalBiological AssayBody Weight decreasedCell Culture TechniquesCellsChiropteraCleaved cellCoronavirusDataDiseaseDisease OutbreaksEducational process of instructingEnzymesFDA approvedFamilyFingerprintFundingGoalsHandHealthHumanImmuneImmune responseIn VitroInterventionKineticsLiverLysineMiddle East Respiratory Syndrome CoronavirusModelingMonitorMurine hepatitis virusMusMutagenesisMutateMutationNatural ImmunityNaturePapainPathogenesisPathologyPeptide HydrolasesPeptidesPhosphoric Monoester HydrolasesPneumoniaPolyproteinsProductionProtease DomainProteinsRNA VirusesRNA chemical synthesisResearchRoentgen RaysRoleSevere Acute Respiratory SyndromeSignaling MoleculeSite-Directed MutagenesisStructureSystemTestingUbiquitinVaccinesViralViral Load resultViral PathogenesisVirusVirus ReplicationWorkbasecytokinedesignin vitro activitymolecular dynamicsnovel viruspandemic diseasepathogenpreferencereplicaseresearch studyresponsereverse geneticstemperature sensitive mutantviral RNA
项目摘要
DESCRIPTION (provided by applicant): The goal of our research is to determine how viral proteases function in the replication and pathogenesis of coronaviruses (CoVs). CoVs are a family of positive strand RNA viruses and include Severe Acute Respiratory Syndrome (SARS) CoV and Middle East Respiratory Syndrome (MERS) CoV which are significant human pathogens with pandemic potential. Previously, we dissected the multifunctional nature of CoV papain-like proteases (PLPs) and found that CoV PLPs cleave the viral replicase polyprotein, act as deubiquitinases (DUBs) and deISGylases (deISGs) by removing ubiquitin (Ub) or ISG15 conjugated to lysine residues on proteins, and that PLPs can antagonize the innate immune response, likely by deubiquitylating signaling molecules. Using detailed biochemical and PLP-Ub co-crystal structural analysis, we identified residues within CoV PLPs that differentially affec enzymatic activity in vitro and in cell-based assays. Our initial studies were performed using SARS-CoV PLpro. Here we provide preliminary in vitro and structural data demonstrating that these results can be extended to the BSL-2 model coronavirus mouse hepatitis virus (MHV-A59) papain-like protease. We hypothesize that multifunctional PLP/DUB activity contributes to viral pathogenesis and that selectively disrupting DUB activity will allow activation of innate immunity and reduced viral pathogenesis. To test this hypothesis, we will determine if a modified PLP/DUB enzymatic activity alters viral replication, innate immune response or pathogenesis. We will use reverse genetics to generate murine CoVs encoding PLPs with distinct enzymatic profiles such as DUB deficient, deISGylation deficient, or hyperactive protease. These novel viruses will be evaluated in cell culture and in mice for kinetics of viral RNA synthesis, production of infectious virus, and kinetics of activation of innate immune responses. To extend these studies to other CoVs, we will determine the enzymatic profile (EP) and enzymatic fingerprint (EF) of alpha- and beta-CoV papain-like proteases including bat CoV PLPs. We will express the PLP domain from 10 different CoV species and determine the peptide cleavage activity, deubiquitinating activity, deISGylating activity, and lysine-linkage preferences for each enzyme. With this profile in hand, we will use existing and new X-ray structures combined to guide mutagenesis experiments to differentially disrupt DUB activity and identify the fingerprint associated with reduced DUB activity. We will also determine the role of differential activity in regulating the innate immune response in bat cells. Also, we identified an
interaction of the CoV ADP-ribose-1"-phosphatase (ADRP) domain with PLP and we will determine the effect of modifying this interaction on enzymatic activity, viral replication and pathogenesis. These studies will reveal new information on viral protease/DUB activity that will be useful for designing antiviral therapies and vaccines for coronaviruses and other protease/DUB-encoding viruses.
描述(由申请人提供):我们研究的目标是确定病毒蛋白酶如何在冠状病毒(CoV)的复制和发病机制中发挥作用。CoV是正链RNA病毒家族,包括严重急性呼吸综合征(SARS)CoV和中东呼吸综合征(MERS)CoV,它们是具有大流行潜力的重要人类病原体。先前,我们剖析了CoV木瓜蛋白酶样蛋白酶(PLPs)的多功能性质,并发现CoV PLPs切割病毒复制酶多聚蛋白,通过去除与蛋白质上的赖氨酸残基缀合的泛素(Ub)或ISG 15作为去泛素化酶(DUB)和去ISGylases(deISG),并且PLPs可以拮抗先天免疫应答,可能通过去泛素化信号分子。使用详细的生物化学和PLP-Ub共晶体结构分析,我们确定了CoV PLPs中的残基,这些残基在体外和基于细胞的测定中差异地影响酶活性。我们的初步研究是使用SARS-CoV PLpro进行的。在这里,我们提供了初步的体外和结构数据表明,这些结果可以扩展到BSL-2模型冠状病毒小鼠肝炎病毒(MHV-A59)木瓜蛋白酶样蛋白酶。我们假设多功能PLP/DUB活性有助于病毒发病机制,选择性破坏DUB活性将允许激活先天免疫和减少病毒发病机制。为了检验这一假设,我们将确定修饰的PLP/DUB酶活性是否改变病毒复制、先天免疫应答或发病机制。我们将使用反向遗传学来产生编码具有不同酶谱的PLP的鼠CoV,所述酶谱例如DUB缺陷、去ISGylation缺陷或高活性蛋白酶。将在细胞培养物和小鼠中评价这些新型病毒的病毒RNA合成动力学、感染性病毒的产生和先天免疫应答激活动力学。为了将这些研究扩展到其他CoV,我们将确定α-和β-CoV木瓜蛋白酶样蛋白酶(包括蝙蝠CoV PLPs)的酶谱(EP)和酶指纹(EF)。我们将表达来自10种不同CoV物种的PLP结构域,并确定每种酶的肽切割活性、去泛素化活性、去ISGylating活性和赖氨酸连接偏好。有了这个配置文件在手,我们将使用现有的和新的X射线结构相结合,以指导诱变实验,以差异破坏DUB活性,并确定与DUB活性降低相关的指纹。我们还将确定差异活性在调节蝙蝠细胞先天免疫反应中的作用。另外,我们发现了一个
我们将研究CoV ADP-核糖-1”-磷酸酶(ADRP)结构域与PLP的相互作用,并确定修饰这种相互作用对酶活性、病毒复制和发病机制的影响。这些研究将揭示有关病毒蛋白酶/DUB活性的新信息,这将有助于设计针对冠状病毒和其他蛋白酶/DUB编码病毒的抗病毒疗法和疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan C. Baker其他文献
A chimeric virus-mouse model system for evaluating the function A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses and inhibition of papain-like proteases of emerging coronaviruses
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Susan C. Baker - 通讯作者:
Susan C. Baker
THE CONVERGENCE OF MULTIPLE MODELS OF MOTIVATION FOR SECOND LANGUAGE LEARNING : GARDNER
第二语言学习多种动机模式的融合:加德纳
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
Maclntyre;Keith MacMaster;Susan C. Baker;Univasitl Colhge d Ca - 通讯作者:
Univasitl Colhge d Ca
Overcome imposter syndrome: Contribute to working groups and build strong networks
克服冒名顶替综合症:为工作组做出贡献并建立强大的网络
- DOI:
10.1016/j.biocon.2024.110566 - 发表时间:
2024 - 期刊:
- 影响因子:5.9
- 作者:
Amanda E. Bates;Megan A. Davies;Rick D. Stuart;Natali Lazzari;J. Lefcheck;Scott D. Ling;Camille Mellin;David Mouillot;Anthony T.F. Bernard;Scott Bennett;Christopher J. Brown;Michael T. Burrows;Claire L. Butler;J. Cinner;Ella Clausius;Antonia T. Cooper;Mark John Costello;Lara Denis;Graham J. Edgar;Yann Herrera Fuchs;Olivia J. Johnson;Cesc Gordó;Cyril Hautecoeur;Leah M. Harper;F. Heather;Tyson R. Jones;Anthony C. Markey;E. Oh;Matthew Rose;Paula A. Ruiz;José A. Sanabria;Jasmin M. Schuster;Joanna K. Schmid;Susan C. Baker - 通讯作者:
Susan C. Baker
Timing and frequency are the critical factors affecting the impact of defoliation on long term growth of plantation eucalypts
- DOI:
10.1016/j.foreco.2017.02.004 - 发表时间:
2017-05-01 - 期刊:
- 影响因子:
- 作者:
Jane A. Elek;Susan C. Baker - 通讯作者:
Susan C. Baker
Monoclonal Antibodies From Children With Acute Kawasaki Disease Identify a Common Antigenic Target in Fatal Cases Over 5 Decades
来自急性川崎病患儿的单克隆抗体在50多年的致死病例中识别出一个共同的抗原靶点
- DOI:
10.1016/j.labinv.2025.104131 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:4.200
- 作者:
Anne H. Rowley;Robert Byrd;David Arrollo;Amornrat O’Brien;Stanford Shulman;Masaru Terai;Kwang-Youn Kim;Kassandra Mercado;Kristine Wylie;Robert Fialkowski;Susan C. Baker - 通讯作者:
Susan C. Baker
Susan C. Baker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan C. Baker', 18)}}的其他基金
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10206579 - 财政年份:2021
- 资助金额:
$ 74.12万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10449132 - 财政年份:2021
- 资助金额:
$ 74.12万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10882676 - 财政年份:2021
- 资助金额:
$ 74.12万 - 项目类别:
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2
研究干扰素拮抗剂延迟对 SARS-CoV-2 的先天免疫反应
- 批准号:
10657457 - 财政年份:2021
- 资助金额:
$ 74.12万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
7987943 - 财政年份:2010
- 资助金额:
$ 74.12万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8099729 - 财政年份:2010
- 资助金额:
$ 74.12万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8485522 - 财政年份:2010
- 资助金额:
$ 74.12万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8686719 - 财政年份:2010
- 资助金额:
$ 74.12万 - 项目类别:
Mechanisms of viral proteases in coronavirus replication and pathogenesis
病毒蛋白酶在冠状病毒复制和发病机制中的机制
- 批准号:
8291352 - 财政年份:2010
- 资助金额:
$ 74.12万 - 项目类别:
Bronchial Epithelial Cultures and Kawasaki Disease
支气管上皮培养与川崎病
- 批准号:
7599596 - 财政年份:2008
- 资助金额:
$ 74.12万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 74.12万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 74.12万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 74.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 74.12万 - 项目类别:
Studentship